Skip to main content
Equibles

MetLife Investment Management, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1529735 Whippany, NJ
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,521,621
-$14,201,029 QoQ
Shares Held
32,716
-89.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#115
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $106,800,407 across 37 Drug Manufacturers - Specialty & Generic names. SUPN ranks #14 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 512,924 $26,877,217
2 UTHR
UNITED THERAPEUTICS Corp
 20,421 $11,064,710
3 NBIX
Neurocrine Biosciences Inc
 51,732 $8,718,911
4 ZTS
Zoetis Inc.
 108,947 $7,828,931
5 HIMS
Hims & Hers Health, Inc.
 224,462 $7,782,097
6 LNTH
Lantheus Holdings, Inc.
 68,281 $7,575,094
7 ELAN
Elanco Animal Health Inc
 240,384 $5,915,850
8 VTRS
Viatris Inc
 266,382 $4,230,146

All Filings in SUPN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,521,621 32,716
2026-03-31 $15,722,650 304,172
2025-12-31 $15,094,685 303,716
2025-09-30 $1,540,176 32,228
2025-06-30 $1,015,826 32,228
2025-03-31 $993,405 30,333
2024-12-31 $1,114,523 30,822
2024-09-30 $917,565 29,428
2024-06-30 $787,199 29,428
2024-03-31 $887,030 26,005
2023-12-31 $752,584 26,005
2023-09-30 $716,957 26,005
2023-06-30 $781,710 26,005
2023-03-31 $942,161 26,005
2022-12-31 $927,598 26,005
2022-09-30 $908,500 26,839
2022-06-30 $805,971 27,869
2022-03-31 $900,726 27,869
2021-12-31 $524,792 17,997
2021-09-30 $479,979 17,997
2021-06-30 $554,127 17,997
2021-03-31 $588,892 22,494
2020-12-31 $565,949 22,494
2020-09-30 $468,774 22,494
2020-06-30 $534,232 22,494
2020-03-31 $404,667 22,494